These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 4367343)

  • 1. Cell-mediated and humoral immunity studies of murine and hamster sarcoma virus-induced producer and non-producer tumors in syngeneic animals.
    McCoy JL; Ting RC; McCoy NT; Reisher JI; Chan SP; Law LW
    Int J Cancer; 1974 May; 13(5):731-41. PubMed ID: 4367343
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of tumor antigens and tumor-specific immune mechanisms in experimental systems.
    Law LW
    Transplant Proc; 1970 Mar; 2(1):117-32. PubMed ID: 4330038
    [No Abstract]   [Full Text] [Related]  

  • 3. Histocompatibility-linked genetic control of specific immune responses to viral infection.
    McDevitt HO; Oldstone BA; Pincus T
    Transplant Rev; 1974; 19(0):209-25. PubMed ID: 4135405
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunology of virus-induced tumours.
    Sjögren HO
    Mod Trends Med Virol; 1967; 1(0):207-22. PubMed ID: 4366129
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 6. Gazdar strain of murine sarcoma virus. Biologic and antigenic interactions with the heterologous hamster host.
    Sarma PS; Gazdar AF; Turner HC; Kunchorn PD
    Proc Soc Exp Biol Med; 1972 Jul; 140(3):928-33. PubMed ID: 4339068
    [No Abstract]   [Full Text] [Related]  

  • 7. H-2 region product as determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes.
    Gomard E; Duprez V; Henin Y; Levy JP
    Nature; 1976 Apr; 260(5553):707-9. PubMed ID: 177884
    [No Abstract]   [Full Text] [Related]  

  • 8. The humoral antibody response to a primary viral neoplasm (MSV) through its entire course in BALB-c mice.
    Lamon EW; Klein E; Andersson B; Fenyö EM; Skurzak HM
    Int J Cancer; 1973 Nov; 12(3):637-45. PubMed ID: 4364795
    [No Abstract]   [Full Text] [Related]  

  • 9. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB; Aoki T; Nunn M; Lavrin DH; Soares N; Gazdar A; Holden H; Chang KS
    J Natl Cancer Inst; 1974 Oct; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract]   [Full Text] [Related]  

  • 10. Derect lymphocyte-mediated cytotoxicity as an assay of presensitisation.
    Garovoy MR; Franco V; Zschaeck D; Carpenter CB; Strom TB; Merrill JP
    Lancet; 1973 Mar; 1(7803):573-6. PubMed ID: 4120643
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic and virologic studies of a nonproducer tumor induced by murine sarcoma virus (Harvey).
    McCoy JL; Ting RC; Morton DL; Law LW
    J Natl Cancer Inst; 1972 Feb; 48(2):383-91. PubMed ID: 4347035
    [No Abstract]   [Full Text] [Related]  

  • 12. Demonstration and identification of cytotoxic antibodies and antibodies blocking the cell-mediated antitumor immunity against adenovirus type 12-induced tumors.
    Ankerst J
    Cancer Res; 1971 Jul; 31(7):997-1003. PubMed ID: 4327089
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune cytolysis of murine tumor cells mediated by xenogeneic "immune" RNA.
    Kern DH; Pilch YH
    Int J Cancer; 1974 May; 13(5):679-88. PubMed ID: 4843880
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune responses to virus induced experimental leukemia and to human leukemia.
    Herberman RB
    Johns Hopkins Med J Suppl; 1974; 3():3-14. PubMed ID: 4371287
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-surface and virion-envelope antigens shared by radiation leukemia virus (RadLV) and other murine c-type viruses.
    Ferrer JF
    Int J Cancer; 1973 Sep; 12(2):378-88. PubMed ID: 4134124
    [No Abstract]   [Full Text] [Related]  

  • 16. Host immunity to a growing transplanted methylcholanthrene-induced guinea pig sarcoma.
    Cohen AM; Millar RC; Ketcham AS
    Cancer Res; 1972 Nov; 32(11):2421-6. PubMed ID: 5082590
    [No Abstract]   [Full Text] [Related]  

  • 17. The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?
    Levy JP; Leclerc JC
    Adv Cancer Res; 1977; 24():1-66. PubMed ID: 66859
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
    Ruddle NH; Armstrong MY; Richards FF
    J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mouse rosette forming cells in transplantation immunity].
    Brondz BD; Eliseeva LS; Kotomina IF; Egorova SG
    Tsitologiia; 1974 Jan; 16(1):74-81. PubMed ID: 4142816
    [No Abstract]   [Full Text] [Related]  

  • 20. The specificity of effector T cells activated by tumours induced by murine oncornaviruses.
    Shellam GR; Knight RA; Mitchison NA; Gorczynski RM; Maoz A
    Transplant Rev; 1976; 29():249-76. PubMed ID: 58459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.